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Determining the number of cases in an epidemic is fundamental to properly evaluate several disease
features of high relevance for public health policies such as mortality, morbidity or hospitalization rates.
Surveillance efforts are however incomplete especially at the early stage of an outbreak due to the ongoing
learning process about the disease characteristics. An example of this is represented by the number of
H1N1 influenza cases in Mexico during the first months of the current pandemic. Several estimates using
backtrack calculation based on imported cases from Mexico in other countries point out that the actual
number of cases was likely orders of magnitude larger than the number of confirmed cases.
Realistic computational models fed with the best available estimates of the basic disease parameters can
provide an ab-initio calculation of the number of cases in Mexico as other countries. Here we use the Global
Epidemic and Mobility (GLEaM) model to obtain estimates of the size of the epidemic in Mexico as well as
of imported cases at the end of April and beginning of May. We find that the reference range for the number
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of cases in Mexico on April 30th is 121,000 to 1,394,000 in good agreement with the recent estimates by
Lipsitch et al. [M. Lipsitch, PloS One 4:e6895 (2009)]. The number of imported cases from Mexico in
several countries is found to be in good agreement with the surveillance data.
This work has been partially supported by the NIH, the NSF, the Lilly Endowment Foundation, DTRA, the
ERC project EpiFor and the FET projects Epiwork and Dynanets. The funders had no role in the
preparation of the article.
An unprecedented global effort in surveillance has been carried out by national and international health
agencies for the current novel Influenza A (H1N1) pandemic [1]. Along with the institutional efforts, a
combination of media attention and new mechanisms for information retrieval, such as Internet, has allowed
the prompt gathering of large amount of data that allow for the first time the real-time analysis of a
pandemic in such a detailed way. Unfortunately, the access and availability of data does not imply reliability
or accuracy. A paramount example is provided by the time evolution of the number of cases in each
country. In the case of influenza, the presence of asymptomatic cases or of cases showing mild symptoms
who might not seek for medical attention lead to an underascertainment of cases that is hard to estimate.
Moreover, the monitoring of cases is expected to change with time, from an enhanced surveillance at the
start of the epidemic, followed by the ascertainment of more severe cases, needing medical attention,
hospitalization, and also confirmation of the infection. This is due to the large increase in the number of
cases overwhelming surveillance systems, which therefore relax their requirements as the epidemic
progresses due to limited capacity and high costs associated with systematic serological testing. For these
reasons, after the very initial stage of the outbreak, the number of confirmed cases tends to be a gross
underestimation of the actual number of infections [2][3][4][5]. On the other hand, reliable figures for the
actual number of cases is the key to the estimate of parameters such as the mortality, morbidity or
hospitalization rates that are on their turn crucial in the policy making process. A paramount example of this
issue is provided by the worries caused by the early estimate of the fatality rate of the current H1N1
pandemic from the Mexican data. As it turned out later, this number was inflated because the confirmed
cases of infections were grossly underestimated in Mexico [2]. In particular, two studies have assessed the
size of the epidemic in Mexico by analyzing the number of H1N1 infected travelers arriving from Mexico
detected by the surveillance systems of other countries in their attempt to contain the epidemic [5][6]. Both
papers find that the estimate for the number of cases in Mexico at the end of April early May is orders of
magnitude larger than those confirmed by Mexican authorities. In particular, the calculation of Ref. [6] that
uses the most updated data source gives a lower bound for the number of cases that is between 113,000
and 375,000 cases, to be compared with the official report that indicate 3,350 confirmed cases [7].
Here, we use the Global Epidemic and Mobility (GLEaM) model [8][9] to provide a computational ab-initio
evaluation of the early size of the outbreak in Mexico and the fluxes of infected travelers to other countries.
The GLEaM model is a spatially structured metapopulation epidemic model [8][9][10][11][12][13][14][15]
[16][17][18][19][20][21], that allows the generation of stochastic realizations of the worldwide unfolding of
the epidemic, with mobility processes entirely based on real data. Once the disease parameters and initial
conditions based on available data are defined, the model generates in-silico epidemics for which we can
gather information such as prevalence, morbidity, number of secondary cases, number of imported cases
and many others for each subpopulation and with a time resolution of one day. In Ref. [9], the GLEaM
model has been used to perform a Maximum Likelihood Estimate (MLE) of the transmission potential of the
current H1N1 pandemic. Here we use the best estimate parameters from Ref. [9] to simulate 2×10 
stochastic simulations of the current pandemic and provide an estimate of the number of H1N1 cases in
Mexico at the date of May the 8th. This is an ab-initio computational estimate and to further cross-validate
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our results, we compare the number of infected individuals traveling from Mexico to other countries from our
simulations and compare these numbers with surveillance reports [6][22][23][24]. We find in our simulations
that in Mexico as of the date of May the 8th the symptomatic cases 95% reference range is 121,000 to
1,394,000. This value is in good agreement with the lower bound estimate of Ref. [6]. The number of
infected individuals with travel history from Mexico in countries such as US, Canada, Spain and UK is also
within the confidence range of our simulations. These results provide further support to the claim that the
number of confirmed H1N1 cases in Mexico is only a very small fraction of the actually occurred cases.
The global epidemic and mobility metapopulation (GLEaM) model is based on a geographically structured
metapopulation approach [8][9][10][11][12][13][14][15][16][17][18][19][20][21][25]. GLEaM is composed of
three layers. The first one is the population layer that integrates distinct census areas for a total of 3362
subpopulations in 220 countries of the world. The census areas are defined by a Voronoi-like tessellation
process that partition the world surface. Given a set of points S in the plane, which are the Voronoi sites,
each site s has a Voronoi cell V(s) consisting of all points closer to s than to any other site. In our partition
we use 3362 major transportation hubs in the world as the Voronoi sites. The boundaries of each
subpopulation are defined by all the points in the plane that are equidistant to two sites. For each area
defined by the cell boundaries and the Voronoi process, the population is obtained from the site of the
”Gridded Population of the World” project of SEDAC (Columbia University) [26] that provides population
estimates worldwide for cells of 15 × 15 minutes of arc. The second layer of the model is composed by the
human mobility flows among the census areas. We consider both commuting flows collected from various
sources in more than 30 countries and the airline traffic provided by IATA [27] and OAG [28]. Further details
concerning the composition of GLEaM and the integration of its three layers for a practical simulation of
epidemic spreading are given in Ref. [9]. The third layer of the model concerns the disease dynamics used
to model the disease evolution. We adopt a SEIR-like compartmentalization framework in which separate
compartments for symptomatic traveling and not traveling, as well as asymptomatic individuals are included
in each different subpopulations. The infection dynamics takes place within each subpopulation and
assumes the classic influenza-like-illness compartmentalization in which each individual is classified by one
of the discrete states such as susceptible, latent, infectious symptomatic, infectious non-symptomatic or
permanently recovered/removed. All transitions are modeled through binomial and multinomial processes to
ensure the discrete and stochastic nature of the processes. A full definition of the model is reported in Ref
[9].
It is also worth stressing here some of the model assumptions. The model is not an agent-based model and
does not include additional structure within a subpopulation, therefore it cannot provide detailed information
at the level of households or workplaces. The fraction of infected population is likely overestimated because
of the assumptions of an entirely susceptible populations and of subpopulations with homogeneous mixing.
Current data on the severity of the pandemic has revealed an age pattern for influenza attack rate shifted
towards the younger age classes of the population [5][29][30][31][32][33][34], suggesting a possible
presence of cross-immunity between the H1N1 pandemic strain and preexisting influenza viruses in the
elderly [35][36][37], besides other mechanisms. This possibility is however still under exploration and no
reliable estimates are available, therefore we assumed a fully susceptible population to study the initial
stage of the outbreak, following previous studies on H1N1 pandemic [5][6][38][39].
The spreading rate of the epidemic is governed by the basic reproduction number and the generation
interval of the specific viral strain considered. In order to obtain best estimate for these parameters the
model has been used to perform a MLE of the parameters against the actual chronology of newly infected
countries [9]. This methodology considers a Monte Carlo generation of the distribution of arrival time of the
infection in each country based on the analysis of one million worldwide simulations of the pandemic
evolution with the GLEaM model. This analysis provides the maximum likelihood estimates for the basic
parameters of the H1N1 such as the reproductive number R  and the basic model parameters e and µ
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defining the inverse average exposed and infectious time durations, respectively. In the following we
consider as the baseline case the set of parameters defined by the best estimates: ε =1.1 days, µ =2.5
days, R  =1.75 [9], consistent with the estimates of Ref. [38]. Asymptomatic individuals are assumed to
represent 1/3 of the total cases, and have a reduced transmissibility of ½ with respect to symptomatic
individuals [9][38][40][41]. The sensitivity analysis and confidence interval for those values are reported in
Ref. [9]. For this set of parameters the model generates quantities of interest such as the profile of the
epidemic behavior in each subpopulation or the number of imported cases. In the following, simulation
results are aggregated at the level of the country for a direct comparison with the empirical data available.
The initial conditions of the epidemic are defined by setting the onset of the outbreak near La Gloria in
Mexico on February 18  , 2009, as reported by official sources [36] and analogously to other works [8]. We
tested different localization of the first cases in census areas close to La Gloria without observing relevant
variations with respect to the observed results. In Mexico we also consider the control measures
implemented in the country starting April 24  and ending May 10th following Ref. [2], as those might affect
the spreading to other countries [9]. Here we focus on the cumulative number of cases observed in Mexico
at the date of April the 30  and the imported cases in the UK, US, Brazil, Germany and France. Each
simulation represents a stochastic realization of the process and we aggregate data on 2×10  realizations
providing reference ranges for all quantities. The data of imported cases are compared with those reported
in Ref. [6] for the UK and the US. The data for France was obtained from Ref. [23], those for Germany from
Ref. [22] and those for Brazil from the reports at the site of the Health Department of the Brazilian
Government [24].
By using GLEaM it is possible to provide a model estimate of the number of imported cases arriving from
Mexico to a set of selected countries. The estimated 99% reference range is shown in Table 1. The dates
and target countries are chosen to facilitate the comparison with the numbers found in the literature [6][22]
[23][24]. The numbers shown in the Table refer to the importantion of infected/exposed individual traveling
from Mexico in one of the listed countries as of the date of May the 8 . Only 2/3 of the exposed travelers
are then considered in the cumulative number of cases as only this fraction will eventually develop
symptoms, according to the model assumptions. The numbers of imported cases to each country are
typically small, and as such prone to large stochastic fluctuations. However the surveillance values are all
within the 99% reference ranges of the 2,000 realizations of our model. We will provide elsewhere a full
sensitivity analysis of the results but we observe very small variations with respect to the presented results
in the range of parameters explored. This is because any MLE for R  and generation interval tend to
optimize the growth rate with respect to the epidemic timeline thus producing very similar results in the early
spreading of the epidemic. We have also considered that in the US the travel history is known only for 50%
of the confirmed cases. The simple extrapolation that provides a twofold estimate of imported cases (in
brackets in Table 1) is however still compatible with the reference range of our stochastic simulations.
Table 2 shows GLEaM predictions for the size of the epidemic in Mexico on April 30  and compare the
results with the estimations of Refs. [5] and [6]. We provide the 95% reference range over 2,000
realizations. The obtained range includes the lower bound estimate of Ref [6]. Our median value for the
number of asymptomatic cases is 734,000 that is again compatible with the range of values reported in Ref.
[6]. While the estimates presented in Refs. [5] and [6] are based on a homogeneous mixing approach within
the entire Mexico, the approach used here is a spatially structured model that just in Mexico counts 65
different census areas. These census areas are not equally connected internationally and between them.
The number of cases relevant for the international spread of infected individuals are mostly in census areas
close to international transportation hubs. Poorly connected regions of Mexico on the other hand, while
experiencing a considerable number of cases, would contribute only marginally to the International spread
of cases. This observation readily explains why single population calculations that match the detection of
imported cases with the local prevalence are necessarily underestimating the latter quantity.
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While GLEaM takes into account a higher level of geographical organization than previous approaches, its
estimates still contain a number of assumptions and approximations. The contagion within each census
area is approximated by means of a homogeneous mixing process. Once a person arrives at a census area
by plane, he/she comes integrated into the local population. This implies that, as in [6], the travelers and the
local population are equally exposed to the disease. Finally, the model considers each individual as
independent and the possibility of cluster cases is not considered. Despite these shortcomings and other
necessary uncertainties, GLEaM predictions might provide additional information for a better understanding
of the early evolution of the present pandemic. Despite the different approximations used here and in Ref.
[6], both approaches are providing support to the possibility of a reporting ratio of infected cases in Mexico
as low as 1 in 100, in agreement with prior estimates [2]. This finding is important when evaluating the
massive amount of data which are now being collected in a large number of countries around the world. We
can easily imagine that the reporting rate as well as any estimate of the cumulative attack rate in most of
the countries could be easily underestimated by orders of magnitude.
AV is consulting and has a research agreement with Abbott for the modeling of H1N1 diffusion. The other
authors have declared that no competing interests exist.
Number
imported cases
(May 8th)
USA UK France Germany Brazil
Simulation
Results
0 – 534 0 – 44 0 – 62 0 – 55 0 – 45
Surveillance
data
85 (170) 17 11 9 3
Table 1: Cumulative number of imported cases from Mexico shown as the 99% reference range over
2,000 realizations on May 8 for a few countries. The simulations are obtained with the best estimate
parameters of the baseline case of Ref. [9] and R0=1.75 [95%CI 1.64 to 1.88]. The number of imported
infected individuals and of independent clusters correspond to the data given in Ref. [6] for US, and UK and
the values in [23] for France, in [22] for Germany and in [24] for Brazil. No data was available to assess the
possible presence of clusters in Germany and France. In the USA we report in parentheses the revised
number considering the rate of unknown travel history in confirmed cases.
Number of symptomatic cases in Mexico (Apr. the
30th)
Simulation Results [121,000 – 1,394,000]
Lower bound range of Ref. [6] 113,000-375,000
Estimate of Ref. [5] * 2,000 – 280,000
Mexican official report [7] (confirmed
cases)
3,350
Table 2: Predictions of GLEaM for the size of the epidemic in Mexico on April 30 in thousands of
cases and comparison with other approaches and with empirical data. The simulations are obtained
with the best estimate parameters of the baseline case of Ref. [9] and show the 95% reference range over
2,000 stochastic realizations. The results are compared with the lower bound estimate range in [6], the
estimate provided in Ref. [5] and the number of confirmed cases given by official reports [27]. *The interval
provided for Ref. [5] is obtained by merging the results reported in the paper under different assumptions
and including the 95% CI.
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